Skip to content

製品

Video: 10 Years of Infinium Array-Powered Progress

Celebrating the last decade of Illumina arrays

10 Years of Infinium Array-Powered Progress
2015/10/27

Throughout the last 10 years, Illumina’s Infinium product line has evolved quickly from genotying common variants, to supporting rare variants, to cost-effectively performing large-scale cohort studies. The Infinium line uses BeadArray microarray technology and encompasses genotyping, methylation, and DNA copy number products for human, animal and plant markets. Before introducing its sequencers, Illumina was solely in the array business and is still highly dedicated to the arrays market and the evolution and advancement of those technologies.

Recent Articles

TruSight Oncology Family Grows with Liquid Biopsy and High-Throughput Assays
TruSight Oncology Family Grows with Liquid Biopsy and High-Throughput Assays
How Sequencing-Based Surveillance Helps Fight COVID-19
How Sequencing-Based Surveillance Helps Fight COVID-19
Illumina Statement on Novel Coronavirus
Illumina Statement on Novel Coronavirus